Testing a prostate marker to predict response to finasteride
Treatments studied
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks at a prostate test marker to understand who is more likely to benefit from 5-ARI medicines such as finasteride or dutasteride. If you have enlarged prostate symptoms and are getting a biopsy, the results may help doctors better choose or interpret 5-ARI treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man age 50 or older
- You have bothersome urine symptoms from an enlarged prostate (BPH)
- Your prostate is larger than 40 cc on exam
- Your PSA blood test is mildly high (above 1.5 and up to 40 ng/ml)
- You are scheduled for a prostate biopsy for elevated PSA
- No suspicious prostate lump/tenderness/firmness found on exam
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests new treatment strategies for benign prostatic hyperplasia (BPH, an enlarged prostate) using a special MRI scan and a medication called finasteride. It aims to find better ways to manage symptoms and identify markers that predict response.
This study looks for urine markers (proteins and metabolites) that may help predict how prostate cancer patients respond to treatment and what their outcomes are. You may be asked to give a urine sample and allow use of your medical and treatment details for analysis (results are not shared with you).
This study compares how well a doctor’s MRI reading (the PI-RADS score) and a computer AI tool detect prostate cancer. It may help improve how men get targeted biopsies and avoid missing important cancers.
This trial tests whether a drug called adalimumab (a TNF blocker) can improve symptoms of an enlarged prostate. It is for men aged 45-80 with a large prostate and bothersome urinary symptoms who have not used this type of medication before.
This study looks for new biological markers in men to improve how prostate cancer is diagnosed and followed. If you have signs that might be prostate cancer, your tests may help researchers find better clues for future care.
This trial tests a new medicine (DNN.65.21.005) to see if it helps men with an enlarged prostate who have trouble urinating. It may be an option if you are 50 or older and have symptoms like needing to go often or having a weak stream.
Hear when a new Benign Prostatic Hyperplasia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.